Rystiggo

MHRA approves Rozanolixizumab for myasthenia gravis patients

Science March 7, 2024

United Kingdom: The Medicines and Healthcare Products Regulatory Agency (MHRA) has approved the medicine Rozanolixizumab (Rystiggo) to treat adults with generalised…

Type above and press Enter to search. Press Esc to cancel.

Editor's Pick

El Niño triggers record September heatwave in Australia

Brazil users regain access to X platform after ban

Biting flies mistake blue objects for prey; Study

Rystiggo

MHRA approves Rozanolixizumab for myasthenia gravis patients

Gautam Adani faces US charges over $250 mn bribery scheme

Pizza Hut UK Operator plans fundraising to offset rising costs

NYC congestion pricing gets green light; Lowered fees set for January rollout

Apple faces legal claim over iCloud pricing and practices

AI-powered Squirrel saviour revolutionises conservation

‘Manifest’ takes top spot as Cambridge Dictionary’s Word of 2024

China unveils Aerospace Innovations at Zhuhai Air Show 2024

Underwater ‘Lighthouses’: China exposes spying devices targeting submarines

AI-powered Squirrel saviour revolutionises conservation

NHS aims to prevent ‘Tripledemic’ with rapid winter vaccination campaign

WHO sounds alarm as Measles cases surge; Calls for renewed vaccine focus

Largest known ‘Coral’ discovered in Solomon Islands; Over 300 years old

We Have

Mass Sled Dog slaughter; Canada issues apology, Announces reparations

Agriculture Secretary nominee Brooke Rollins completes Trump Cabinet

AI-powered Squirrel saviour revolutionises conservation

COP29: Historic $300bn pledge to aid developing Nations